Literature DB >> 22951018

Microparticles and acute renal dysfunction in septic patients.

Margit Tőkés-Füzesi1, Gábor Woth, Balázs Ernyey, István Vermes, Diana Mühl, Lajos Bogár, Gábor L Kovács.   

Abstract

PURPOSE: The role of microparticles (MPs) in the pathogenesis of sepsis is not completely elucidated. We aimed to assess changes in the number of MPs during severe sepsis to follow the effect of sepsis-related organ failures, particularly renal impairment, an independent mortality factor of sepsis.
MATERIALS AND METHODS: Thirty-seven severe septic patients and 20 controls were enrolled. Patient status as well as organ failure-related laboratory markers was followed up to 5 consecutive days. Microparticles (annexin V+ events in MP size gate) of platelet (CD41, CD42a, and PAC1), monocyte (CD14), and myeloid cell line (CD13) origin were measured using flow cytometry.
RESULTS: Significantly increased total MP and CD41-, CD42a-, and PAC1-positive particle numbers were found in septic patients compared with controls. Actual number of organ dysfunctions on sample collection showed no correlation with MP numbers. Septic patients with renal dysfunction showed an increase in total MP, CD41(+), and CD13(+) particle numbers on admission. Amounts of platelet-derived CD42a(+) particles from patients with sepsis-related renal injury correlated negatively with actual blood urea nitrogen and creatinine concentrations.
CONCLUSION: The increased numbers of platelet-derived MPs in severe septic patients emphasize the possible contribution of the hemostasis system in the development of sepsis-related renal impairments.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22951018     DOI: 10.1016/j.jcrc.2012.05.006

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


  18 in total

Review 1.  Extracellular vesicles in renal disease.

Authors:  Diana Karpman; Anne-Lie Ståhl; Ida Arvidsson
Journal:  Nat Rev Nephrol       Date:  2017-07-24       Impact factor: 28.314

Review 2.  Microparticle analysis in disorders of hemostasis and thrombosis.

Authors:  Micah J Mooberry; Nigel S Key
Journal:  Cytometry A       Date:  2015-02-20       Impact factor: 4.355

3.  Differential biomarker profiles between unprovoked venous thromboembolism and cancer.

Authors:  V Sánchez-López; L Gao; M Ferrer-Galván; E Arellano-Orden; T Elías-Hernández; L Jara-Palomares; M I Asensio-Cruz; M J Castro-Pérez; F J Rodríguez-Martorell; J L Lobo-Beristain; A Ballaz-Quincoces; J L López-Campos; V Vila-Liante; R Otero-Candelera
Journal:  Ann Med       Date:  2020-07-15       Impact factor: 4.709

Review 4.  Extracellular Vesicles in Renal Diseases: More than Novel Biomarkers?

Authors:  Uta Erdbrügger; Thu H Le
Journal:  J Am Soc Nephrol       Date:  2015-08-06       Impact factor: 10.121

5.  Therapeutic Potential of Extracellular Vesicles for Sepsis Treatment.

Authors:  Stephanie M Kronstadt; Alex E Pottash; Daniel Levy; Sheng Wang; Wei Chao; Steven M Jay
Journal:  Adv Ther (Weinh)       Date:  2021-04-29

Review 6.  A Pathophysiological Insight into Sepsis and Its Correlation with Postmortem Diagnosis.

Authors:  C Pomara; I Riezzo; S Bello; D De Carlo; M Neri; E Turillazzi
Journal:  Mediators Inflamm       Date:  2016-04-27       Impact factor: 4.711

Review 7.  Update on sepsis-associated acute kidney injury: emerging targeted therapies.

Authors:  James F Doyle; Lui G Forni
Journal:  Biologics       Date:  2016-11-07

8.  Effect of Platelet-derived P-selectin on Neutrophil Recruitment in a Mouse Model of Sepsis-induced Acute Kidney Injury.

Authors:  Xiu-Hua Li; Yong-Bing Qian; Xiao-Xiao Meng; Rui-Lan Wang
Journal:  Chin Med J (Engl)       Date:  2017-07-20       Impact factor: 2.628

Review 9.  Microvesicle Involvement in Shiga Toxin-Associated Infection.

Authors:  Annie Villysson; Ashmita Tontanahal; Diana Karpman
Journal:  Toxins (Basel)       Date:  2017-11-19       Impact factor: 4.546

Review 10.  Blood platelets and sepsis pathophysiology: A new therapeutic prospect in critically [corrected] ill patients?

Authors:  Antoine Dewitte; Sébastien Lepreux; Julien Villeneuve; Claire Rigothier; Christian Combe; Alexandre Ouattara; Jean Ripoche
Journal:  Ann Intensive Care       Date:  2017-12-01       Impact factor: 6.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.